6.98 USD
▼-0.16-2.24%
盘后 6.32 0.00%
2026-11-19
市值
$714.99M
市盈率
—
EPS
-1.61
股息率
—
52 周区间
4.73 – 9.54
成交量
495.31K
Beta
0.44
目标价
16.60
52W 低 4.7352W 高 9.54
价格走势
公司简介
Aura Biosciences, Inc., a clinical-stage biotechnology company, develops precision therapies to treat solid tumors. The company’s proprietary platform enables the targeting of a range of solid tumors using virus-like particles conjugated with drugs or loaded with nucleic acids to create virus-like drug conjugates. Its lead candidate is bel-sar, which is in late-stage clinical development for the treatment of patients with primary choroidal melanoma and other ocular oncology indications, as well as in early-stage clinical development in bladder ...